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Background: Environmental factors such as tobacco exposure, indoor climate and diet are known to be involved
in the development of allergy related diseases. The aim was to determine the impact of altered exposure to these
factors during pregnancy and infancy on the incidence of allergy related diseases at 2 years of age.
Methods: Children from a non-selected population of mothers were recruited to a controlled, multicenter
intervention study in primary health care. The interventions were an increased maternal and infant intake of n-3
PUFAs and oily fish, reduced parental smoking, and reduced indoor dampness during pregnancy and the children’s
first 2 years of life. Questionnaires on baseline data and exposures, and health were collected at 2 years of age.
Results: The prevalence of smoking amongst the mothers and fathers was approximately halved at 2 years of age
in the intervention cohort compared to the control cohort. The intake of n-3 PUFA supplement and oily fish among
the children in the intervention cohort was increased. There was no significant change for indoor dampness. The
odds ratio for the incidence of asthma was 0.72 (95% CI, 0.55-0.93; NNTb 53), and 0.75 for the use of asthma
medication (95% CI, 0.58-0.96). The odds ratio for asthma among girls was 0.41 (95% CI 0.24-0.70; NNTb 32), and for
boys 0.93 (95% CI 0.68-1.26). There were no significant change for wheeze and atopic dermatitis.
Conclusion: Reduced tobacco exposure and increased intake of oily fish during pregnancy and early childhood
may be effective in reducing the incidence of asthma at 2 years of age. The differential impact in boys and girls
indicates that the pathophysiology of asthma may depend on the sex of the children.
Trial registration: Current Controlled Trials ISRCTN28090297.
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The International Study of Asthma and Allergies in
Childhood (ISAAC) has shown variations in the prevalence
of allergy related diseases and that the worldwide time
trend is increasing, particularly in developing countries
[1,2]. Asher et al. suggested several factors to be involved,
including lifestyle, dietary intake, microbial exposure,
economic status, indoor and outdoor environment,
climatic variation and awareness of disease [2]. The identi-
fication of which of these factors should be considered for* Correspondence: christian.dotterud@gmail.com
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reproduction in any medium, provided the orearly intervention and their effectiveness in counteracting
the increasing incidence of allergy related diseases depends
on the results of controlled intervention studies [3].
The Prevention of Allergy among Children in Trondheim
(PACT) study was established to evaluate the possibility of
reducing the prevalence of allergy related diseases in
children within the constraints of public funding and time
expenditure in primary health care [4]. Participants, regard-
less of parental history of atopy were included, as a large
proportion of allergy related diseases develop in “low risk”
groups [5,6], and “. . .a large number of people at small risk
may give rise to more cases of disease than a small number
who are at high risk” [7]. Smoking and environmentalal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ated fatty acids (n-3 PUFAs) [9-11], and indoor dampness
[12,13], were associated with the development of allergy
related diseases and were of particular scientific interested
when this study commenced. We have previously reported
a significant reduction in parental smoking and increased
intake of oily fish and n-3 PUFAs in the intervention cohort
compared to the control cohort [4]. We have also shown a
risk reduction from eating oily fish once a week or more at
1 year of age in terms of parental reported atopic dermatitis
(AD) at 2 years of age [14]. The impact of altered exposure
to these factors through a population based intervention on
the incidence of allergy related diseases is unknown [15,16].
It is generally accepted that there are sex differences in the
incidence of asthma in children, and studies which clarify
the sex related factors in the development of asthma are
needed [16].
The aim of the PACT study was to examine the feasibility
and effectiveness of a non-targeted population-based
intervention to decrease parental smoking and indoor
dampness and to increase intake of oily fish and n-3
PUFA. The impact of the intervention was evaluated in
terms of the prevalence of parentally-reported allergy
related diseases at 2 years of age.
Methods
Design and participants
The PACT-study is an on-going controlled, multicentre
interventional study, described in detail elsewhere [4]. Here
we present the results from when the children were 2 years
of age. The study was conducted in Trondheim, a city in
the central part of Norway with 165 000 inhabitants and
about 2100 births a year. The participants in both the
control cohort and the intervention cohort followed the
ordinary scheduled program for pre- and postnatal
follow-up in primary health care.
The intervention cohort included women who pre-
sented to their GP or midwife for routine pregnancy
check-ups after the implementation of the intervention
in June 2002. Recruitment to the intervention cohort
ended in May 2006. The control cohort recruitment
commenced in September 2000 and consisted of
pregnant women and children recruited at 6 weeks,
1 year and 2 years of age during routine check-ups with
GPs and midwives across Trondheim. The recruitment
of pregnant women to the control cohort ceased when
recruitment into the intervention group commenced.
When the first child in the intervention cohort was six
weeks old, the recruitment of six-week-old children to
the control cohort ceased, and analogously when they
were 1 and 2 years of age. All women in the community
who received an invitation to join the study, were willing
and able to complete a questionnaire in Norwegian, and
gave a written informed consent to participate wereincluded. In this study, questionnaires on baseline data
and all relevant exposures were collected during pregnancy
and at 2 years of age. At the same time a questionnaire on
the child’s health were collected, which was adapted to
the age group from the ISAAC questionnaire [17], and
tested for reliability in a separate study [18]. The health
questionnaire focused on allergy related diseases and use
of medication.
The intervention program was implemented by the
City Government as a part of recommended maternity
care and life-style counselling throughout the city,
regardless of participation in the PACT-study or not.
The smoking cessation intervention was adapted from
the United States Department of Health and Human
Services Public Health Service (USHPS) guideline
"Treating Tobacco Use and Dependence” [19]. The
dietary intervention was advice of intake of oily fish
twice a week and 1.2 g n-3 PUFA a day (5 ml cod liver oil)
during pregnancy. After birth intake of n-3 PUFA to the
child was recommended from 4–6 weeks and intake of
oily fish at least twice a week from 6 months of age. In the
indoor dampness intervention, advice on how to detect
housing dampness damage and how to reduce exposure to
indoor dampness were given.
Parental smoking was assessed at 2 years of age
through two questions asking the women if they, or their
partner, were smoking at start of pregnancy, and if they
were smoking now. Information on consumption of n-3
PUFA, lean fish (cod and coalfish) and oily fish (redfish,
halibut, salmon, trout, herring and mackerel) as dinner
and sandwich spread were collected using validated semi
quantitative food frequency questions with six categories,
and re-categorized later in the analyses [20,21]. Housing
conditions and indoor dampness were assessed through the
reported presence of eight different indicators of indoor
dampness, including mouldy or musty smell, moist
cardboard and newspapers after storage, dew on windows,
moist spots on ceilings, walls or wallpapers, leakage detec-
tion on water pipes or faucet, leakage from roof or ground,
or moisture in the floors. Dampness index was defined by
the sum of reported dampness indicators with a sum ≥3 as
the cutoff. In a separate study, information on education
was collected from a sample of the control cohort and the
intervention cohort by telephone interviews.
The primary outcome measure was based on a paren-
tal reported health questionnaire targeted to allergy
related diseases. Allergic rhinoconjunctivitis (ARC) was
not included as an outcome variable since incidence is
low and an exact diagnosis of ARC is uncertain at 2 years
of age. A child was considered to have asthma if the par-
ents answered yes to “Has the child ever been diagnosed
with asthma by a doctor?” Two questions in combination
defined wheeze: “Has your child ever had whistling in the
chest?” and “Has your child ever had episodes of wheezing
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defined AD: “Has the child ever had eczema?” and
“Has the child ever had an itchy rash which come and
went over at least 6 months?” Parental atopy was
defined as a history of asthma, ARC or AD in either
the mother or father.
Statistical analyses
The presentation of the results and interpretations
follow the TREND recommendations for public health
intervention research [22]. STATA (version 12.1 IC) was
used for all statistical analysis.
Logistic regression was used to estimate crude odds
ratios for each of the exposure variables and outcome
variables in the intervention cohort compared with the
control cohort. To estimate adjusted odds ratios (aOR)
we used multilevel logistic regression models with a
random intercept for each maternal health care centre.
This model accounted for possible clustering of partici-
pants within different centres. All demographic variables
(except education and parental smoking), and infectious
diseases and use of antibiotics were considered as
possible confounding factors, and were tested in separate
multilevel logistic models for alteration on the effect
estimator. In the final model, adjustments were made for
birth weight, maternal atopy, and RS-virus infection. To ad-
just for possible between-centre confounders we adjusted
for the mean number of participants from the intervention
cohort within each maternal health care centre.
In a sub-analysis, the differential impact of sex on the
behavioural and outcome measures were tested with an
interaction term between sex and cohort, and further
stratified by sex to obtain separate ORs for boys and
girls. In a sub-analysis, the differential impact of parental
smoking (mother or father at 2 years of age) on the
outcome measures were tested with an interaction term
between parental smoking and cohort, and further strati-
fied by parental smoking to obtain separate ORs for
asthma among children with smoking and non-smoking
parents. In the trend analysis, we used binary logistic
regression to estimate p-values for trend in both cohorts.
In the analysis of the differences between the participants
at 2 years of age and drop-outs in the prenatal question-
naire on exposures was used. For all other data, the
questionnaires on exposures and health from 2 years were
used. Two-sided significance tests were used, with p < 0.05
considered statistically significant. For interaction terms,
p < 0.10 were considered statistically significant.
Ethical approval
The study was approved by the Regional Committee
for Medical Research Ethics for Central Norway
(Ref. 120–2000). The Norwegian Data Inspectorate gave
permission to process personal health data and one of theparents signed a written informed consent form
(Ref 2003/953-3 KBE/-). The study is registered in Current
Controlled Trials: ISRCTN28090297.
Results
Participants
Thirty-two of a total of 35 general practices, all seven
community midwifes, and all 20 maternal health care
centres recruited participants. The numbers of participants
and time of inclusion are illustrated in Figure 1. The partici-
pants at 2 years of age in the intervention cohort and con-
trol cohort were comparable except from smoking status,
single mothers and breastfeeding (Table 1).
In the intervention cohort, 2860 participants were
included during pregnancy, and 1374 (48.0%) of these
could be followed prospectively until 2 years of age.
When comparing these participants (n = 1374) to the
drop-outs (n = 1486), the age of the mothers were 29.3
(SD 4.18) and 28.5 (SD 4.60), the number of maternal
smokers at start pregnancy were 257 (19.8%) and 345
(24.1%), the numbers of paternal smokers at start
pregnancy were 223 (17.4%) and 335 (24.1%), and
1116 (83.2%) versus 1057 (70.7%) were homeowners,
respectively. There were no differences between the
participants and drop-outs regarding education, parity,
parental atopy, and pets.
In the control cohort, 1796 pregnant women were
included during pregnancy, and 833 (46.4%) of these
could be followed prospectively until 2 years of age.
When comparing these participants (n = 833) to the
drop-outs (n = 963), the age of the mothers were 29.2
(SD 4.61) and 28.2 (SD 4.75), the number of maternal
smokers at start pregnancy were 204 (25.1%) and 273
(29.5%), the numbers of paternal smokers at start
pregnancy were 171 (21.9%) and 244 (27.7%), and 660
(79.8%) versus 652 (68.5%) were homeowners, respectively.
Again, there were no differences between the participants
and drop-outs regarding education, parity, parental
atopy, and pets. Additionally, 3947 participants who
were recruited to the control cohort after birth com-
pleted the 2 years questionnaire, giving a total of 4780
participants at 2 years.
Behavioural changes
At 2 years of age, the prevalence of smoking amongst
mothers (OR = 0.46; p < 0.01; Table 2) and fathers
(OR = 0.57; p < 0.01) was almost halved in the intervention
cohort compared to the control cohort. Intake of n-3 PUFA
supplement was about 10 percentage points higher in
the intervention cohort compared to the control cohort
(OR = 1.46; p < 0.01). The proportion having oily fish at
least once a week was about 15 percentage points higher
in the intervention cohort (OR = 1.86; p < 0.01), and
the intake of lean fish about 3 percentage points lower
Questionnaire Q1b
n=2860
Control cohort 
(Cross-sectional)
Children 2 years postnatal:
Na=9100
Inclusion:
Started September 1st 2000 
Stopped December 30th 2004
Questionnaire Q2c
n=4780
Intervention cohort
(Follow-up)
Pregnant women at first antenatal 
check-up: 
Na=8400
Inclusion 
Started June 1st 2002
Ended May 30th 2006
Questionnaire Q2c
n=1374
Drop-outs
n=1486
Figure 1 Flow of participants in the intervention cohort and control cohort. a Total population of birth cohort in Trondheim during
inclusion period. b Q1 = Completed questionnaire on exposures at first antenatal check-up during pregnancy. c Q2 = Completed questionnaires
on exposures and health at 2 years of age.
Table 1 Demographic characteristics of participants at 2 years of age
Characteristic Intervention cohort N = 1374 Control cohort N = 4780
Mean (SD) Mean (SD)
Age mother at delivery (years) 29.8 (4.21) 29.3 (4.68)
Educationa mother (years) 15.8 (2.43) 15.5 (2.58)
Educationa father (years) 15.1 (2.77) 15.0 (2.97)
Birthweight (grams) 3601 (545) 3582 (594)
n (%) n (%)
Boys 667 (49.3) 2389 (50.0)
One or more sibling 915 (67.4) 3265 (69.3)
Premature 162 (11.9) 671 (14.4)
Single mother 50 (3.8) 356 (7.7)
Breast fed ≥6 months 1053 (76.9) 3285 (69.3)
Smoking mother at start pregnancy 186 (13.8) 862 (18.6)
Smoking father at start pregnancy 205 (15.7) 917 (21.3)
Atopyb mother 652 (47.8) 1991 (42.4)
Atopyb father 578 (42.3) 1725 (36.8)
Atopy mother and father 304 (22.3) 865 (18.4)
Dog in dwelling 104 (7.6) 365 (7.7)
Cat in dwelling 150 (11.0) 397 (8.4)
Homeowner 1247 (91.4) 4118 (87.4)
a Education data is based on a sample (Intervention cohort: n = 1062. Control cohort: n = 1242).
b Defined as ever having had asthma, allergic rhinoconjunctivitis or AD.
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Table 2 Prevalence and odds ratios of exposures at 2 years of age
Intervention cohort N = 1374 Control cohort N = 4780 Odds ratioa (95% CI)
n (%) n (%) Crude Adjustedb
Smoking mother at 2 years of age 132 (9.8) 879 (19.0) 0.46 0.47
(0.38-0.56) (0.39-0.58)
Smoking father at 2 years of age 143 (11.2) 751 (17.9) 0.57 0.56
(0.47-0.69) (0.46-0.68)
Indoor dampness index 53 (3.9) 179 (3.8) 1.02 1.09
(0.75-1.39) (0.79-1.51)
1.2 g n-3 PUFA four times a week or more 582 (42.6) 1591 (33.6) 1.46 1.42
(1.29-1.66) (1.25-1.62)
Any kind of fish once a week or more 1011 (73.6) 3369 (70.6) 1.16 1.13
(1.02-1.33) (0.98-1.30)
Oily fish once a week or more 687 (50.0) 1667 (34.9) 1.86 1.83
(1.65-2.11) (1.61-2.09)
Lean fish once a week or more 836 (61.3) 3062 (64.6) 0.87 0.85
(0.76-0.98) (0.74-0.97)
aFor intervention cohort versus control cohort.
bAdjusted for birthweight, maternal atopy, RS-virus infection, maternal health care centre, and the proportion of participants from each cohort in each public
health centre.
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reported by approximately 4% of the participants in
both cohorts (OR = 1.02; p = 0.90).
Incidence of allergic diseases
The incidence of parentally reported doctor diagnosed
asthma in the intervention cohort compared with the
control cohort was reduced (OR = 0.72; p = 0.01; Table 3).
The absolute risk reduction (ARR) was 1.9% and
numbers needed to treat to benefit (NNTb) was 53. The
risk of using asthma medication during the last 12 months
was correspondingly lower in the intervention cohortTable 3 Incidence and odds ratios of allergy related diseases
Intervention cohort N = 1374 Control cohor
Boys
n (%)
Girls
n (%)
Total
n (%)
Boys
n (%)
Girl
n (%
Asthma 55 16 71 208 129
(8.1) (2.3) (5.2) (8.7) (5.4
Used asthma medication
last 12 months
60 19 79 222 138
(8.9) (2.7) (5.8) (9.3) (5.8
Wheeze 201 139 340 702 553
(30.7) (20.4) (25.4) (30.3) (23.9
AD 109 107 216 427 360
(16.5) (15.8) (16.1) (18.5) (15.5
Ever used allergy
medication
45 31 76 168 130
(6.7) (4.5) (5.6) (7.1) (5.5
aFor intervention cohort versus control cohort.
bAdjusted for birthweight, maternal atopy, RS-virus infection, maternal health care c
health centre.(OR = 0.75; p = 0.02). The differences between the inter-
vention and control cohorts with respect to the risk of
wheeze (OR = 0.92; p = 0.23) and AD (OR = 0.94; p = 0.47)
were smaller and statistically non-significant.
Subgroup analysis stratified by sex disclosed a differential
impact on asthma (p for interaction <0.01) and the use of
asthma medication (p for interaction =0.01; Table 3).
Among the boys, the impact on an asthma diagnosis was
non-significant (OR = 0.93; p = 0.63), and correspondingly
non-significant on asthma medication (OR = 0.95; p = 0.73).
Among the girls, however, the impact on asthma
(OR = 0.41; p < 0.01; NNTb 32) and the use of asthmaamong 2 years old children
t N = 4780 Odds ratioa (95% CI)
s
)
Total
n (%)
Boys crude Girls crude Total crude Total adjustedb
337 0.93 0.41 0.72 0.68
) (7.1) (0.68-1.26) (0.24-0.70) (0.55-0.93) (0.52-0.90)
360 0.95 0.46 0.75 0.69
) (7.5) (0.70-1.28) (0.28-0.74) (0.58-0.96) (0.53-0.91)
1255 1.02 0.82 0.92 0.91
) (27.1) (0.84-1.23) (0.66-1.00) (0.80-1.05) (0.79-1.06)
788 0.87 1.02 0.94 0.93
) (17.0) (0.69-1.10) (0.81-1.30) (0.80-1.11) (0.78-1.10)
298 0.94 0.81 0.88 0.87
) (6.3) (0.67-1.32) (0.54-1.20) (0.68-1.14) (0.66-1.15)
entre, and the proportion of participants from each cohort in each public
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Subgroup analysis stratified by sex showed a borderline
non-significant differential impact of the intervention on
wheeze (p for interaction 0.12). Among the boys, the im-
pact on wheeze was non-significant (OR = 1.02; p = 0.85).
While it was borderline non-significant for girls
(OR = 0.82; p = 0.06), there was no differential impact
of the intervention for AD in the subgroup analysis
(p for interaction 0.34).
Subgroup analysis stratified on parental smoking at
2 years of age disclosed no differential impact of the
intervention on asthma (p for interaction 0.71). The
ORs for asthma in the intervention cohort compared
with the control cohort among children with smoking
parents (OR = 0.80; p = 0.45) and non-smoking parents
(OR = 0.71; p = 0.02) were comparable.
Other potential confounders
Comparisons of reported infectious disease and use of
antibiotics among the children at 2 years of age are
presented in Table 4. There was an increased risk of
intestinal infection (p < 0.01), in the intervention cohort
compared with the control cohort. There were no statis-
tically significant differences between the intervention
and control cohorts with respect to the risk of RS-virus
infection, false croup, bronchitis, pneumonia, and the
use of antibiotics. There were no statistically significant
sex differences on infectious disease and use of antibiotics
in either cohort (data not shown).
Annual trend analysis
No statistical significant annual trends were found with
respect to asthma in either the intervention cohort
(OR = 0.92; p = 0.51) or the control cohort (OR = 0.97;
p = 0.52). No statistical significant annual trends wereTable 4 Distribution of potential confounders of reported
infectious disease and use of antibiotics among 2 years
old children
Intervention cohort
N = 1374
Control cohort
N = 4780
Odds ratioa
n (%) n (%) (95% CI)
Ever RS virus
infection
75 (5.5) 209 (4.4) 1.26 (0.96-1.65)
Ever intestinal
infection
373 (27.2) 864 (18.1) 1.68 (1.46-1.94)
Ever false croup 188 (13.7) 675 (14.2) 0.96 (0.81-1.14)
Ever bronchitis 185 (13.5) 692 (14.6) 0.92 (0.77-1.09)
Ever pneumonia 87 (6.4) 345 (7.3) 0.87 (0.68-1.11)
Ever used
antibioticsb
601 (44.0) 2196 (46.1) 0.92 (0.81-1.03)
aFor intervention cohort versus control cohort.
bEver used antibiotics for cold, inflammation of the ear, bronchitis, RS-virus
infection, false croup, pneumonia, urinary infection and gut infection.found with respect to the use of asthma medicines in
the intervention (OR = 1.07; p = 0.58) and the control
cohort (OR = 1.04; p = 0.30).
Discussion
We found a significantly lower incidence in parental-
reported doctor diagnosed asthma and use of asthma
medication at 2 years of age in the intervention cohort
compared to the control cohort. The reduced incidence
for both asthma and the use of asthma medication was
observed among girls. There was no significant difference
in the incidence of AD and wheeze between the interven-
tion and control cohorts, and similarly no difference was
observed when the groups were stratified by sex.
The behavioural changes are described in details else-
where [4,23]. Briefly, the participants in the intervention
cohort smoked significantly less, had an increased intake of
oily fish and n-3 PUFAs, but the same levels of indoor
dampness compared to participants in the control cohort.
As we did not find any difference between the cohorts
regarding indoor dampness, the reduced incidence of
asthma could not be ascribed to this interventional
measure. The study was not designed to identify the
magnitude of effect of individual interventions, and it
remains therefore uncertain if the observed reduction in
asthma is solely due to the reduction in tobacco smoke
exposure or dietary alterations or a combination of both.
Prenatal and postnatal smoke exposure is generally
considered to be a strong risk factor for the development
of respiratory symptoms and asthma, particularly in
early life [24,25]. The first national comprehensive mass
media campaign on tobacco and health for many years
in Norway was accomplished during the study period in
2003, and a total ban on smoking in restaurants and
cafés first took effect on June 1st 2004. According to
WHO´ s European health for all database, the preva-
lence of regular daily smokers above 15 years of age in
Norway has gradually declined during the study period,
from 31.2% in year 2000 to 21% in 2008 [26]. In the sub-
analysis of this study, the impact of the intervention
among children with smoking and non-smoking parents
was comparable. This may indicate that the reduced
incidence of asthma in the intervention cohort was not a
consequence of reduced parental smoking per se. Rather,
reduced smoking in Norway in general and smoking
bans in public places could have contributed to less ETS
exposure of the children in the intervention cohort
independent of the smoking status of their parents. In
randomised controlled trials dietary supplementation
with n3-PUFAs does not seem effective in reducing the
incidence of asthma as showed in a meta-analysis [27].
However, fish intake during pregnancy and during the
first year of life has been found to be associated with a
reduced risk of childhood asthma [28-30]. Summarised,
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ETS exposure on childhood asthma is stronger than the
evidence of a preventive effect of fish. As such, the
reduced incidence of asthma and use of asthma medica-
tion in the intervention cohort may be attributed first
and foremost to the reduced ETS exposure of the
children and secondly to the increased intake of fish.
The trend analysis showed no annual trends in either
cohorts regarding asthma. This indicates that the
reduced risk of asthma in the intervention cohort was
not a consequence of an annual time trend.
We found no differences between the cohorts regarding
AD. We have previously reported a negative association
between the intake of fish in childhood and AD at 2 years
of age [14]. The increased fish consumption in the
intervention cohort compared with the control cohort
was likely too small to have an impact on AD on popu-
lation level [4].
Our results demonstrated a strong differential impact
on asthma and use of asthma medicines when stratified
by sex. For wheeze, a similar differential impact was
found, but was not statistically significant. An observa-
tional study has showed prenatal and postnatal exposure
to tobacco smoke to be associated with asthma in 2 years
old girls only [31], and cigarette smoking is associated
with more respiratory symptoms among adolescent and
adult women than among men [32,33]. A previous
randomised intervention to reduce house dust mite, pet
and food allergens, and passive smoking in a high-risk
population of infants found an effect of the intervention
on asthma-like symptoms in girls, but not on boys [34].
In line with this, our results indicate that the asthma
phenotype among girls at 2 years of age is more suscep-
tible to ETS and intake of oily fish than that of boys.
The differential impact on boys and girls may indicate
that the pathophysiology of asthma depends on the sex
of the child.
The strengths of this study are the interventional,
non-selected, population-based design with a large
number of participants. The PACT study recruited
participants from a primary health care population,
regardless of parental history of atopy. The control
cohort was established over a 2 year period immediately
before the intervention was started, and from the same
socio-economic areas. Participants in both cohorts
followed the same scheduled program for pre- and
postnatal follow-up in primary health care. Choosing a
controlled design including whole birth cohorts made it
possible to test the impact of the intervention program
with a real life approach. A randomised control trial,
with a co-existing cohort, would not be feasible in this type
of broad population intervention, as both participants and
health care workers move or communicate with each other
introducing contamination of the control group. Secondly,comparing total birth cohorts also ensured high conformity
between the cohorts regarding population size, race/eth-
nicity, maternal educational level, income, environment,
urbanisation and social characteristics. The assessment of
allergy related diseases were consistent through the
observation period in both cohorts, and questions
reporting factual information such as doctor diagnosed
asthma were found reliable in a separate study [18].
Some 35% of the eligible pregnant women in Trondheim
completed the questionnaires at 2 years of age. We had
almost no active withdrawals in either cohort. The
participation rate dropped during the study period [4],
and could be a consequence of the long duration of
the study resulting in a decreasing awareness, causing
low recruitment activity among many GPs and midwifes,
and not a consequence of self-selection among women.
Decreased participation rate has been an increasing
problem in epidemiological studies the recent years, but
the participation rate experienced in this study might
not introduce biased estimates if the participants are
representative [35]. Results from the additional non-
participants study (n = 391), showed no significant
differences between non-participants and participants in
the PACT study [23]. This is reassuring and indicates
that the PACT population is comparable to the general
maternal population in Trondheim.
The drop-outs in in the intervention cohort were
different from the participants at 2 years of age regarding
maternal age, maternal smoking at start pregnancy and
homeowner status, but the clinical differences were
small. Due to the design of the study, only a portion of
the control cohort was followed prospectively from
pregnancy, however similar differences were seen between
the drop-outs and participants in the intervention and
control cohorts.
The participation rate varied between each maternal
health care centre and they had a somewhat different
proportion of participants from each cohort. Multilevel
logistic regression models compensated for possible
clustering on maternal health care centre. The proportion
of participants from each cohort in each public health
centre was added as a separate variable to the model to
compensate for the different participant rates from each
cohort in each maternal health centre. We were able to
adjust for a large number of confounders, including RS
virus infection and other potential clinical confounders.
Summarised in the final adjusted model, the aOR of allergy
related diseases was comparable with the crude analysis
(Table 3). This indicated that the effect estimates were not
biased. We were unable to adjust for education due to lack
of parental educational data on all participants. Parental
homeowner status was tested in the adjusted model as a
proxy for socioeconomic status, but did not alter the effect
estimates, and was excluded in the final adjusted model.
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Reduced environmental tobacco smoke and increased
intake of oily fish during pregnancy and early childhood
may be effective in reducing the incidence of asthma at
2 years of age in primary health care. The differential im-
pact in boys and girls indicates that the pathophysiology
of asthma is dependent on the sex of the child.
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